Awaiting product image

Biological Drug Product, Formulation, mAb Formulation

Secukinumab biosimilar

Categories: Biological Drug Product, Formulation, mAb Formulation

Description

• Phase 1 clinical trial ongoing

• Phase 3 clinical trial ongoing

First patient in Oct. 2022